Recent Finacing
Recent Raise
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing small-molecule single-agent and combination therapies targeting multiple mechanisms (FXR, VAP‑1, THR‑β) for NASH and chronic liver diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Terns Pharmaceuticals.
